ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1346

The Presentation and Outcomes of Surgically Treated Septic Arthritis:  the Impact of Culture Results

Ziv Paz1, Mary Louise Fowler2, Clara Zhu3, Sarah B. Lieber1, Andrew Moore4 and Robert H. Shmerling5, 1Beth Israel Deaconess Medical Center, Boston, MA, 2School of Medicine, Boston University School of Medicine, Boston, MA, 3Medical School, Boston University School of Medicine, Boston, MA, 4Medicine, Cambridge Health Alliance, Harvard Medical School, Cambridge, MA, 5Medicine, Beth Israel Deaconess Medical Center, Boston, MA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Arthritis, Infection, surgery and synovial fluid

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Infection-related Rheumatic Disease: Poster Session

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Clinically-suspected septic
arthritis is culture-negative in 18-43% of cases.  These patients are often treated surgically
with associated morbidity, prolonged hospital stays and high medical costs.  Patients with culture-negative (CN) septic
arthritis may differ in important ways from their culture-positive (CP)
counterparts, including the possibility that such patients could be
successfully managed without surgery. The purpose of our study is to compare
the clinical characteristics and outcomes between CN and CP patients with
surgically-treated septic arthritis.

Methods: We conducted a retrospective study that
included all patients ages 18 and older admitted to a single, tertiary-care
hospital between 1998 and 2015 who were diagnosed with monoarticular
septic arthritis and were treated with antibiotics and surgery. We excluded all
cases of osteomyelitis and polyarticular or
prosthetic joint infection.

Results: Of 314 patients with clinically suspected
and surgically treated septic arthritis, 104 were CN and 210 were CP.  The groups were similar with regard to age,
gender and presence of associated comorbidities [Table 1]. Though,
significantly more CP patients had known, pre-existing joint pathology
(p=0.003). The most common joint affected was the knee, which was more
frequently involved in the CN group (p=0.03), while the shoulder was more often
involved in the CP group (p=0.01) [Figure 1]. 
The clinical presentations and outcomes differed significantly between
the two groups with more severe disease [Table 1] and less favorable outcomes
[Table 2] noted among those in the CP group. Nearly 10% of patients in the CN
group were diagnosed with another cause of inflammatory arthritis within one
year of follow-up.

Conclusion: This study suggests that patients
presenting with suspected septic arthritis have less severe disease and better
outcomes when their synovial fluid cultures are negative. Many CN patients are
diagnosed with another cause of inflammatory arthritis in follow-up.  Non-surgical treatment may be appropriate for
patients with suspected septic arthritis when synovial fluid cultures are
negative.


Disclosure: Z. Paz, None; M. L. Fowler, None; C. Zhu, None; S. B. Lieber, None; A. Moore, None; R. H. Shmerling, None.

To cite this abstract in AMA style:

Paz Z, Fowler ML, Zhu C, Lieber SB, Moore A, Shmerling RH. The Presentation and Outcomes of Surgically Treated Septic Arthritis:  the Impact of Culture Results [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/the-presentation-and-outcomes-of-surgically-treated-septic-arthritis-the-impact-of-culture-results/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-presentation-and-outcomes-of-surgically-treated-septic-arthritis-the-impact-of-culture-results/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology